Abraxis BioScience
| Industry | Pharmaceutical |
|---|---|
| Founded | 2001 in Los Angeles, California[1] |
| Founder | Dr. Patrick Soon-Shiong |
| Defunct | 2010 |
| Headquarters | , United States |
Key people |
|
| Products | Protein-based therapeutics and technologies for treatment of cancer and other critical illnesses |
| Brands | Abraxane |
| Services | Cancer drugs |
| Revenue |  US$359 million (2009)[2] |
 US$−113 million (2009)[2] | |
| US$−104 million (2009)[2] | |
| Total assets | US$1.068 billion (2009)[2] |
| Total equity | US$846 million (2009)[2] |
| Owner | Celgene |
Number of employees | 885 (2009)[2] |
Abraxis BioScience was a global biopharmaceutical, and nano-medicine company that developed treatments for critically ill patients. It had over 2000 employees worldwide in 2007. Abraxis's portfolio included the world's first protein-based nanoparticle chemotherapeutic compound, called nab Technology.[3] From this the company developed Abraxane, a treatment for metastatic breast cancer.[4]
In 2010, Abraxis BioScience was acquired by Celgene Corporation.[5]
History
[edit | edit source]Abraxis was incorporated in 2001 in Los Angeles.[1] It was formerly known as American Pharmaceutical Partners (APP), which as known for its injectable oncology, anti-infective and critical care.[6] Besides cancer treatments, it provided treatment for multiple sclerosis, Alzheimer's, and some cardiovascular diseases.[1] It had manufacturing plants in Melrose Park, Illinois and Phoenix, Arizona.[1] By 2005, Dr. Patrick Soon-Shiong merged American BioScience and the publicly-held APP, naming it Abraxis BioScience.[7] Under this new name, seventy-four trials were undertaken to test Abraxane against various cancer targets.[7] The drug, which was approved by the FDA in 2005, was the subject of a litigation (Elan Pharma v. Abraxis BioScience) for patent infringement.[8] In 2008, Abraxis was ordered to pay $55.2 million to Elan.[8]
In August 2007, Abraxis announced it would again undergo a restructuring to separate its "hospital-based products business" from its "proprietary products business" into two public companies; this would involve the merging of Abraxis Oncology and Abraxis Research sub-units to form a new Abraxis Bioscience (Abraxis Bioscience, Inc., Nasdaq: ABII), and the spinoff of Abraxis Pharmaceutical Products (APP, Inc., Nasdaq: APPX).[9] This reorganization was completed in November 2007.[10] During the reorganization, the new Abraxis Bioscience was known briefly as New Abraxis.[10]
In 2010, Abraxis BioScience was acquired by Celgene Corporation.[5] Per Celgene's website, as of at least 2016 Abraxis no longer exists as a named division within Celgene.[citation needed]
References
[edit | edit source]- ^ a b c d Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ a b c d e f Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Abraxis BioScience, 2008, "Nab Technology", 10/11/2009
- ^ Hoovers. Archived 2015-09-24 at the Wayback Machine
- ^ a b Celgene, 30 June 2010, "Celgene To Acquire Abraxis BioScience Inc." (press release), 8/6/2015.
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ a b Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ a b Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ a b Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
External links
[edit | edit source]Lua error in mw.title.lua at line 392: bad argument #2 to 'title.new' (unrecognized namespace name 'Portal').
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
- Defunct biotechnology companies of the United States
- Defunct pharmaceutical companies of the United States
- Biotechnology companies established in 2001
- Pharmaceutical companies established in 2001
- 2001 establishments in California
- Biotechnology companies disestablished in 2010
- Pharmaceutical companies disestablished in 2010
- 2010 disestablishments in California
- Health care companies based in California
- 2010 mergers and acquisitions
- Defunct technology companies based in New York City
- American companies disestablished in 2010
- American companies established in 2001
- Medical company stubs